{"schema_version":"secwatch.filing_event.v1","accession":"0001703057-26-000035","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2026-06-17T16:38:25+00:00","discovered_at":"2026-06-17T16:39:00.249809+00:00","generated_at":"2026-06-17T16:39:11.902203+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"AbCellera announces $56M upfront collaboration with Jazz Pharma for T-cell engager antibodies","bullets":["$56M upfront for first two programs; $28M additional upon initiation of third program within 12 months.","Up to $792M per program in option fees and milestones plus mid-single to low-double-digit royalties on net sales.","Collaboration targets gastrointestinal cancers and other solid tumors using AbCellera's T-cell engaging multispecific platform.","Jazz holds exclusive worldwide rights to develop and commercialize after exercising option for each program.","AbCellera may also conduct IND-enabling studies and manufacture clinical supply for programs under the collaboration."],"urls":{"canonical":"https://secwatch.observer/filing/0001703057-26-000035","json":"https://secwatch.observer/filing/0001703057-26-000035.json","markdown":"https://secwatch.observer/filing/0001703057-26-000035.md","text":"https://secwatch.observer/filing/0001703057-26-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000035/0001703057-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000035/abcl-20260617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:39:11.902203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}